ArticlePLoS computational biology2026
Transcriptomic-guided whole-slide image classification for molecular subtype identification.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advancements in computational pathology have greatly improved automated histopathological analysis. A compelling question in the field is how morphological traits are associated with genetic characteristics or molecular phenotypes. Here we propose TEMI, a novel framework for molecular subtype classification of cancers using whole-slide images (WSIs), augmented with transcriptomic data during training. TEMI aims to extract molecular-level signals from WSIs and make efficient use of available multimodal data. To this end, TEMI introduces a patch fusion network that captures dependencies among local patches of gigapixel WSIs to produce global representations and aligns them with transcriptomic embeddings attained from a masked transcriptomic autoencoder. TEMI achieves superior performance compared with existing methods in molecular subtype classification, owing to its effective integration of transcriptomic information achieved by the two developed alignment strategies. Guided by discriminative transcriptomic data, TEMI learns invariant WSI representations, while morphological features also enhance gene expression prediction. These findings suggest that histological features encode latent molecular signals, highlighting the interplay between the tumor microenvironment and cancer transcriptomics. Our study demonstrates how multimodal learning can bridge morphology and molecular biology, providing an effective tool to advance precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.